Eosinophilic Disease of the Bowel...051005_Lindenbaum_DDW 1 Eosinophilic Disease of the Bowel C....

45
051005_Lindenbaum_DDW 1 Eosinophilic Disease of the Bowel C. Cuffari, M.D. Division of Pediatric Gastroenterology and Nutrition Johns Hopkins University School of Medicine

Transcript of Eosinophilic Disease of the Bowel...051005_Lindenbaum_DDW 1 Eosinophilic Disease of the Bowel C....

  • 051005_Lindenbaum_DDW 1

    Eosinophilic Disease of the Bowel

    C. Cuffari, M.D.Division of Pediatric Gastroenterology and Nutrition

    Johns Hopkins University School of Medicine

  • 051005_Lindenbaum_DDW 2

    Objectives

    • To discuss clinical presentations of patients with a protein allergy or intolerance

    • Discussion on FPIES

    • To discuss eosinophilc esophagitis: pathogenesis, clinical presentation, therapy and future research

  • What triggers an eosinophil response?

    • Food antigens: Cows milk protein, soy protein, beef protein. Other antigens like egg albumin, etc.

    • Infections: Giardia lamblia, roundworm, hookworm, CMV, Ascaris.

    • Medications: Post transplant meds (FK506), Gold based therapies for arthritis, chemotherapeutic agents.

    • Environmental stimuliWalker-Durie, Pedatric GI disease 3rd edition

  • Pathogenesis

    • Both IgE mediated and IgE independent mechanisms are important in the development intolerances

    • Allergic patients with intolerances tend to have higher total IgE and tissue IgE on IF, compared to non allergic patients who have increased IgA and IgM.

    • Eosinophil recruitment and activation is induced by IL 3, GM-CSF and IL 5

  • IgE-Mediated

    Non-IgE-Mediated

    Anaphylaxis

    Immediate GI hypersensitivity

    Oral allergy syndrome

    Eosinophilic Esophagitis

    Eosinophilic Gastritis

    Eosinophilic Enteritis

    Eosinophilic Colitis

    Enterocolitis syndrome

    Dietary protein proctitis

    Celiac Disease

    Gastrointestinal Food Hypersensitivity

  • Increasing Food Specific IgE or Skin Test Size

    Tests should not be interpreted as just positive or negative but rather as the probability of indicating true food allergy

    Interpretation of Food Allergy Test Results

  • 051005_Lindenbaum_DDW 7

  • IL-3,GM-CSF,IL-5 in EGEPierre Desreumaux, Jean-Frederic Colombel and Anne Janin.Gastro 1996;110:768-774.

    • IL-13, GM-CSF, IL-5 were increased in the GI tract of patients with intolerances.

    • The presence of these cytokines was associated with a dense eosinophil infiltration of the lamina propria in the small bowel and colon.

    • IL-5 supports the proliferation and terminal differentiation of eosinophil precursors and also prolongs the survival of mature eosinophils as well as a chemotactic factor.

    • The genes for IL-13, GM-CSF and IL-5 are clustered on the long arm of Chr 5 (5q23-22).

  • 051005_Lindenbaum_DDW 9

    Adverse Reactions to Food

    Adverse

    Food

    Reaction

    IgE

    Nonimmune

    Mediated

    (Food

    Intolerance)

    Immune

    Mediated

    (Food

    Allergy) Non-IgE

    Enzymatic

    Pharmacological

    Undefined

  • 051005_Lindenbaum_DDW 10

    Gastrointestinal Manifestations of Protein Allergy or Intolerance

    • Gastroesophageal reflux / vomiting

    • Colic / irritability / abdominal pain

    • Gastrointestinal bleeding

    • Diarrhea

    • Constipation

    • Heartburn / chest pain

    • Difficulty swallowing

    • Failure to thrive

  • 051005_Lindenbaum_DDW 11

    Commonly Implicated Foods

    • Cow milk

    • Soy

    • Wheat

    • Egg

    • Nuts

    • Seafood

  • 051005_Lindenbaum_DDW 12

    Allergic Proctocolitis

    • Age at onset– 1 day to 6 months (most 2-8 weeks)

    • Family history– High prevalence of atopy

    • Manifestations– Blood-streaked, soft-to-loose stools

    – Fecal leukocytes

    – Low risk for anemia

    – Infant well appearing

    • Implicated antigens– Cow milk soy, egg, corn

  • 051005_Lindenbaum_DDW 13

    Allergic Proctocolitis Pathology

    • Endoscopic

    – Colitis (erythema, friability, erosions)

    • Microscopic

    – eosinophilia or lymphoid nodular hyperplasia

  • 051005_Lindenbaum_DDW 14

    Management of Allergic Proctocolitis

    • Elimination of food allergen

    – Maternal dietary restriction

    – Casein hydrolysate formula

    – Amino acid formula for severe cases

    • Gross bleeding typically resolves within 72 hrs

    • Occult bleeding may take several weeks to resolve

  • 051005_Lindenbaum_DDW 15

    Protein Enterocolits

    • Age of onset– 1 day to 1 year

    • Manifestations– Emesis

    – Abdominal Distention

    – Failure to thrive

    – Hypotension

    – Metabolic acidosis

    – Blood in stools

    – Fecal leukocytes and reducing substances

    • Implicated antigens– Cow milk, soy, rice, poultry, fish

  • 051005_Lindenbaum_DDW 16

    Management of Protein Enterocolitis

    • Casein hydrolysate formula successful 90% of time

    – Amino acid formula needed in ~10% cases

    – Nasogastric feedings may be required in severe cases of malabsorption

    • Symptoms resolve within 1 week

    • If cow milk protein implicated, 50% tolerance by 18 months, 90% by 36 months

  • 051005_Lindenbaum_DDW 17

    Less than 2 years of age at first presentation (frequent feature but not

    mandatory)

    Exposure to the incriminated food elicits repetitive vomiting and/or

    diarrhea within 4 h without any other cause for the symptoms.

    Repeated exposure to causative food elicits gastrointestinal symptoms

    without alternative cause.

    Absence of symptoms that may suggest an IgE-mediated reaction.

    Avoidance of the offending protein from the diet results in resolution of

    symptoms.

    Re-exposure or oral food challenge elicits typical symptoms within 2−4

    h. Two typical episodes are needed to deliver the definitive diagnosis

    Food protein-induced enterocolitis syndrome

    (FPIES)

  • 051005_Lindenbaum_DDW 18

    Acute FPIES Chronic FPIES

    Important and repetitive vomiting Regurgitation, small amounts

    (constant)

    Lethargy (frequent) Lethargy

    Hyporeactivity (frequent) Failure to thrive

    Pallor (frequent) Dehydration

    Diarrhea Diarrhea, sometimes bloody

    Dehydration (rare) Abdominal distention

    Hypothermia (rare)

    Hypotension (rare)

    Acute and chronic FPIES clinical

    manifestations

  • Allergy Prevention-Infants

    • Estimated 2-3% infants develop food allergies

    • Many allergies continue on into childhood and adulthood

    • Increased duration of exclusive BF associated w/ decrease in childhood allergy

    • Many studies have examined other methods in preventing allergies in infancy and childhood

  • Allergy Prevention- Infants

    • Preventative Measures:

    – maternal allergen avoidance during pregnancy and lactation

    – exclusively breastfeeding

    – avoidance of potential allergens until 12mo

    – hydrolyzed formulas: changing the protein to make it less allergenic

  • Meta-analysis, Osborn 2007

    • To determine whether hydrolyzed formulas (HF) are preventative in allergies and food intolerances; what type of formula and which infants will benefit

    • Included in analysis were randomized trials with > 80% participant follow up (n=18)

    • Comparison of hydrolyzed infant formulas to HM or cow’s milk formulas (CMF)

    The Cochrane Library, Issue 4, 2007

  • Meta-analysis, Osborn 2007Results:

    • 14/18 studies used high-risk infants

    The Cochrane Library, Issue 4, 2007

  • Meta-analysis, Osborn 2007Results:

    • Partially HF vs CMF (n=7)– significant reduction in allergy

    Prolonged use of HF vs CMF (n=12)– significant reduction in all infant allergies,

    some into childhood

    • Extensively HF vs Partially HF with prolonged use (n=3)

    – no significant difference in allergy or food intolerance The Cochrane Library, Issue 4 2007

  • Meta-analysis, Osborn 2007Discussion/Conclusion:

    • No evidence that HF better than HM in short term or prolonged use

    • There is evidence of benefit from HF vs CMF for prevention of allergy in infants and children

    • “When babies are not exclusively breastfed, using hydrolyzed infant formulas instead of ordinary cow’s milk and soy milk formulas can reduce allergies in babies and children at significant risk”

    The Cochrane Library, Issue 4 2007

  • Prebiotic (Oligosaccharide) Additionto Infant Formula

    • “Food” for beneficial bacteria in the gut

    • Not digested in upper GI tract

    • Oligosaccharides added to mimic breast milk prebiotic function

    • Alter intestinal microflora to favor beneficial bacteria to support the developing GI and immune

    systems

  • 26

    Prebiotics Are Oligosaccharides That Are Added to Infant Formulas to Support Beneficial Bacteria in the Gut

    Prebiotics travel through the GI tract undigestedby human enzymes

    (Prebiotic)

    to reach the colon and serve as “food” for the beneficial bacteria

  • 27

    Galactooligosaccharides (GOS) Have BeenExtensively Studied in Infant Formulas

    7 In Vitro

    Studies

    Gal Gal GlcGal Gal Gal GlcGal33 Animal

    Studies

    15 Infant Studies

    (>2000 infants)

    15 Adult

    Studies

  • GOS/FOS (9:1) Increased IgA More Like the Breastfed Infant

    Bakker-Zierikezee AM, van Tol EAF, Kroes H, et al. Pediatr Allergy Immunol. 2006; 17:134-140

    Breast Milk

    (n=22)

    Median Fecal Secretory IgA

    0

    0.2

    0.4

    0.6

    0.8

    1

    1.2

    16 weeks of age

    Med

    ian

    Fecal

    sIg

    A

    (mg

    /g/w

    et

    wt)

    *p < 0.05 when compared with the standard formula

    group

    Prebiotics

    (n=14)

    *

    Control

    (n=14)

  • GOS/FOS (9:1) Cumulative Incidence of Allergy Decreased

    Arslanoglu S, et al. J Nutr 2008:138;1091-1095

    *p

  • 051005_Lindenbaum_DDW 30

    Eosinophilic GI Disorders

    • Both IgE mediated and IgE independent mechanisms are involved

    • Include eosinophilic esophagitis, gastroenteritis and colitis

  • 051005_Lindenbaum_DDW 31

    Triggers of an Eosinophilic Response

    • Food antigens

    • Parasitic infections

    • Medications

    • Environmental stimuli

  • 051005_Lindenbaum_DDW 32

    Symptoms Associated with Eosinophilic Esophagitis (EE)

    • Vomiting / reflux

    • Epigastric pain

    • Heartburn

    • Dysphagia

  • NEJM 2004 August, Aug 26;351(9):940-1.

    Eosinophilic Esophagitis: Rising Incidence:

    Editorial

    Noel RJ, Putnam PE, Rothenberg ME.

  • 051005_Lindenbaum_DDW 34

    Age of Diagnosis in Study of 381 Children with EE

    Liacouras CA et al, Clin Gastroenterol Hepatol, 2005

  • Eosinophilic Esophagitis in Children: Symptoms, Histology and pH Probe Results.

    • Median age at presentation was 10.8 years (range, 1-17 years ).

    • Symptoms: Dysphagia with solid food (66%), Abdominal pain (42%), vomiting (8%).

    • Food allergy was reported in 50% and asthma in 33%.

    • Esophageal pH probe monitoring, performed in nine patients, revealed no abnormal acid reflux . Episodic alkalinization of the esophagus

    • Upper endoscopic : White specks on the esophageal mucosa in 42%, esophageal narrowing in 33%, esophageal rings in 25%, and esophageal furrowing in 8%

    • Mean eosinophils per high-power field was 65 (range, 20-200).

    • Histologic characteristics included peripapillary clusters of eosinophils (33%), increased papillary height (50%), and basal cell hyperplasia (34%).

    J Pediatr Gastroenterol Nutr. 2004 Oct;39(4):373-377. Sant'Anna AM, Rolland S, Fournet JC, Yazbeck S, Drouin E

  • • Thickened pale mucosa with longitudinal furrow and fold pattern and absent vascular pattern.

    • Pin-point white exudate.

    • GASTROINTESTINAL ENDOSCOPY VOLUME 57, NO. 1, 2003

  • 051005_Lindenbaum_DDW 37

    EE Histopathology

    Parfitt JR et al, Mod Pathol 2006

  • Eosinophils

  • Pathophysiology

    • EoE has been shown to be a Th2-mediated disorder

    – Includes both IgE and non-IgE mediated response to food allergen

    • High rates of association with other allergic disease

    – 28 – 86% of adults– 42 – 93% of pediatric patients

  • Medical Treatment Options

    • Allergic referral

    – RAST or skin prick testing for food allergen triggers

    – Food elimination diet

    • Topical steroids

    – Swallowed Fluticasone propionate

    – Viscous budesonide

    • Systemic steroids

    • The use of PPI is not universally recommended.

  • Fluticasone Proprionate

    • DOSE: No fixed recommendations.

    2-4 years : 44mcg/puff 2 puffs b.i.d. x 6-8wk

    5-10 yrs : 110mcg/puff

    11-21 yrs: 220mcg/puff

    Do not eat or drink for 30 minutes after consuming the medications

    Some studies have treated for as long as 12 weeks and some for as short as 4 weeks.

    No studies have commented on recurrent use and dosage as well as maintenance of remission.

  • 051005_Lindenbaum_DDW 42

    Effect of Amino Acid-Based Formula on Esophageal Eosinophil Counts

    Liacouras CA et al, Glin Gastroenterol Hepatol, 2005

  • 051005_Lindenbaum_DDW 43

    Pre- and Post-treatment Peak Esophageal Eosinophil Counts after Six-Food Elimination Diet

    Kagalwalla AF et al, Clin Gastroenterol Hepatol, 2006

  • Suggested management approach

    • Treatment of UGI symptoms for 6-8 weeks with acid blockade with high dose PPI

    • If symptoms persist EGD with proximal and distal biopsy

    • If histology suggests EE pH probe to rule out acid contribution

    • Consultation with allergist for identifiable dietary and environmental allergens

    • Treatment with allergen avoidance, 6 food elimination diet, elemental diet or corticosteroids with endpoints of symptom relief and mucosal healing with

    decrease eosinophils

    • Follow up for long term complications including stricture formation.

    Eosinophilic esophagitis: it’s not just kid’s stuff; GI endoscopy; Vol 56, No 2, 2002. V Gox, S Nurko, G Furuta.

  • 051005_Lindenbaum_DDW 45

    Summary

    • Food intolerances in childhood are common, especially in high risk patient populations;

    • Preventive strategies have proven efficacy;

    • Prebiotic formulas may be beneficial;

    • Eosinophilic proctitis: common and easy to manage

    • Eosinophilic esophagitis is common and most patients require prolonged therapy.